CGS 15943
CAS No. 104615-18-1
CGS 15943 ( —— )
Catalog No. M23255 CAS No. 104615-18-1
CGS 15943 is an orally bioavailable non-xanthine antagonist of Adenosine Receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 82 | In Stock |
|
10MG | 120 | In Stock |
|
25MG | 201 | In Stock |
|
50MG | 300 | In Stock |
|
100MG | 448 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCGS 15943
-
NoteResearch use only, not for human use.
-
Brief DescriptionCGS 15943 is an orally bioavailable non-xanthine antagonist of Adenosine Receptor.
-
DescriptionCGS 15943 is an orally bioavailable non-xanthine antagonist of Adenosine Receptor. In transfected CHO cells, its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM , respectively.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAdenosine A1?receptor;adenosine A2A receptor;adenosine A2B receptor;adenosine A3 receptor;p110γ;p110δ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104615-18-1
-
Formula Weight285.7
-
Molecular FormulaC13H8ClN5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:12.22 mg/mL (42.77 mM; Need ultrasonic)
-
SMILESC1=COC(=C1)C2=NN3C(=N2)C4=C(C=CC(=C4)Cl)N=C3N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gao Y, et al. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci. 1994;55(3):PL61-5.
molnova catalog
related products
-
Theobromine
3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants.
-
PNU 282987
PNU-282987 is a selective α7 nicotinic acetylcholine receptor(α7 nAChR) agonist with Ki of 26 nM; no affinity for α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM).
-
Galanthaminone
Galanthaminone is a cholinesterase (AChE) inhibitor?is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments.